Articles for the ‘General’ Category
Overview Of Changes in Information Security and Personal Data Protection Affecting Wholesale and Retail Trade of Medicinal Products in Russia
Key updates in Russian data security & healthcare CII: New rules for personal data consent (effective Sept 2025), healthcare CII categorization, and penalties for non-compliance. Essential for pharma & medical retailers
... Read moreMisleading claims may infringe competition law
Published 04 March 2025 by Anders Thue
Simonsen Vogt Wiig, Norway
Misleading claims (so-called “denigration”) about competitors’ medicinal products or devices may be illegal, as several recent cases from the European Commission and national competition authorities illustrate. Even if the allegations are not incorrect in themselves, their totality and framing (“what is not said”) can still cross the line. Companies must be very careful with this type of “information campaigns”.
... Read more
Online platform and the prohibition of sale of medicinal product not subject to medical prescription: the CJEU rules that a factual analysis of the role of the platform must be conducted
Published 23 September 2024 by Fabrice Perbost
Harlay Avocats, France
The Court of Justice of the European Union’s judgment of 29 February 2024 sheds light on the question of whether Member States may prohibit the activities of e-commerce platforms operating in the field of medicinal products not subject to medical prescription.
The case involved the www.doctipharma.fr website which was edited and operated by the French company Doctipharma SAS (“Doctipharma”). The website connected pharmacists with customers and allowed the latter to buy medicinal products not subject to compulsory medical prescription from pharmacies websites.
... Read more
Changes In Regulatory Framework for Dietary Supplements in Russia: What Is to Be Expected?
On 9 July 2024, the State Duma passed Bill in first reading, which focuses on changes in the regulatory regime for the circulation of dietary supplements in Russia.
The proposed amendments would introduce significant changes affecting the circulation of dietary supplements and, to a certain extent, bringing it closer to the regime established for pharmaceuticals and medical devices.
... Read moreAdvertisement of Medicines Directed to the Public
Published 13 August 2024 by Cristina Hernández Lería
Lener, Spain
The regulation of public advertising medicines in Spain aims to ensure that promotional practices are transparent, accurate, and responsible. This includes adhering to authorized technical details, presenting dosage information clearly, and avoiding misleading claims about efficacy. Advertising should be informative and comprehensible, avoiding exaggeration and ensuring that all claims are substantiated by technical data. This article explains in more detail what needs to be considered if you intend to advertise medicines in the Spanish market.
... Read more